Nature Outlook 

Fatty liver disease

The worldwide increase in obesity and diabetes has led to a spike in non-alcoholic fatty liver disease, which often progresses to the more severe condition non-alcoholic steatohepatitis. This Outlook discusses topics such as the surge in drug development that is poised to deliver new treatments; how innovative technologies are enabling earlier diagnosis; and the disturbing rise of fatty liver disease in children.

This Nature Outlook is editorially independent. It is produced with third party financial support. About this content.

Features and comment

Related research